Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.
Menu

Rx Item-Mirtazapine 45MG 500 Tab by Rising Pharma USA Somerset

Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051Rx items can only be ordered by a valid licence holder in scope of practice by-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,PhysicaCitron Pharma LlcImage 4 of Rx Item-Mirtazapine 45MG 500 Tab by Rising Pharma USA Somerset

Rx Item-Mirtazapine 45MG 500 Tab by Rising Pharma USA Somerset

$1416.67$252.57

Rx Item-Mirtazapine 45MG 500 Tab by Rising Pharma USA Somerset , Only Physician, Pharmacy Or Licensed Facility Can purchase this RX Item.Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051 Drug Category:Psychotherapeutic Agents-Antidepressants-Tetracyclic Antidepressants Drug Class: Drug Class: 28160492 Antidepressants Misc. Other Names:Mirtazapine Oral Tablet 4, Mirtazapine , Mirtazapin

Have a question?

REMERON- mirtazapine tablet, film coated
Organon Pharmaceuticals USA

Suicidality and Antidepressant Drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of REMERON� (mirtazapine) Tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. REMERON is not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use)

DESCRIPTION

REMERON� (mirtazapine) Tablets are an orally administered drug. Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c] benzazepine and has the empirical formula of C17 H19 N3 . Its molecular weight is 265.36.

CLINICAL PHARMACOLOGY

Pharmacodynamics
The mechanism of action of REMERON (mirtazapine) Tablets, as with other drugs effective in the treatment of major depressive disorder, is unknown.
REMERON Indications and Usage

REMERON (mirtazapine) Tablets are indicated for the treatment of major depressive disorder.
DOSAGE AND ADMINISTRATION

Initial Treatment
The recommended starting dose for REMERON (mirtazapine) Tablets is 15 mg/day, administered in a single dose, preferably in the evening prior to sleep. In the controlled clinical trials establishing the efficacy of REMERON in the treatment of major depressive disorder, the effective dose range was generally 15 to 45 mg/day. While the relationship between dose and satisfactory response in the treatment of major depressive disorder for REMERON has not been adequately explored, patients not responding to the initial 15-mg dose may benefit from dose increases up to a maximum of 45 mg/day. REMERON has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should not be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for evaluation of the therapeutic response to a given dose.

Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051
Rx Item-Mirtazapine 45MG 500 Tab by Risi
Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051

Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051
Rx Item-Mirtazapine 45MG 500 Tab by Risi
Item No. RX417340, 417340, NDC No.: 57237-0010-05, 57237-010-05, 5723701005, 57237001005, 0010-05, 001005 UPC No. 3-57237-01005-1, 357237-010051, 357237010051

Rx items can only be ordered by a valid licence holder in scope of practice by-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physica
Rx Item-Mirtazapine 45MG 500 Tab by Risi
Rx items can only be ordered by a valid licence holder in scope of practice by-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physica